• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content

Addiction Treatment

Coverage of addiction treatment including smoking cessation, alcohol use, and opioids
Home » Topics » Addiction Treatment
  • April 21, 2026
    By Michael Weaver, MD, FASAM

    Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).



  • April 21, 2026
    By Michael Weaver, MD, FASAM

    Naltrexone (ReVia, Vivitrol) Fact Sheet

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).



  • April 21, 2026
    By Michael Weaver, MD, FASAM

    Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet

    Gabapentin is effective as an off-label medication to ease alcohol withdrawal symptoms and to reduce cravings over the long term in patients with alcohol use disorder (AUD).



Read More
  • April 21, 2026
    By Michael Weaver, MD, FASAM

    Disulfiram (Antabuse) Fact Sheet

  • April 21, 2026
    By Michael Weaver, MD, FASAM

    Acamprosate (Campral) Fact Sheet [G]

  • April 1, 2026

    Learning Objectives, Drug Trends CATR, April/May/June 2026

  • April 1, 2026

    CME Post-Test, Drug Trends, CATR, April/May/June 2026

  • April 1, 2026
    By Brian Holoyda, MD, MPH, MBA

    Prescription Drug Misuse and Diversion in Correctional Settings

  • Catr aprmayjun2026
    April 1, 2026
    By Jared Bozeman, MD

    What Psychiatrists Should Know About Inhalants

  • Catr qa1 joseph palamar photo sm
    April 1, 2026
    By Joseph Palamar, PhD

    Trends in Illicit Drug Use

  • April 1, 2026
    By Jared Bozeman, MD

    Family Support in Substance Use Disorders

  • April 1, 2026
    By Jasleen Kaur, MD

    Oral vs Injectable Naltrexone for Hospitalized Patients With AUD

  • April 1, 2026
    By Jasleen Kaur, MD

    Higher Buprenorphine Doses Lower Death Rates in the Fentanyl Era

Read More

Blog Posts

  • Topics most read
    December 18, 2025

    Top 10 Clinical Topics of 2025 (All Newsletters)

  • Shutterstock 2689265667
    October 13, 2025
    By Noah Capurso, MD

    Psychedelics and Addiction Psychiatry

  • Shutterstock 2683817953
    September 29, 2025
    By Noah Capurso, MD

    The Rise of Long-Acting Buprenorphine

  • Shutterstock 2470299055
    June 3, 2024
    By Noah Capurso, MD

    Contingency Management with Dr. Dominick DePhilippis

  • Dea checkbox
    May 24, 2024

    How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Read More

Products

  • Tas platinum 6

    Platinum Level - Newsletters (Print and Online), Podcast CME, Webinar CME, Complete eBook Access and Toolkit

    $849.00$799.00
    Save 6%
    Subscribe
  • Tas platinum online only 6

    Platinum Level - Newsletters (Online-Only), Podcast CME, Webinar CME, Complete eBook Access and Toolkit (Online-Only)

    $749.00$649.00
    -15%
    Subscribe
  • Tas gold 5

    Gold Level - Newsletters (Print and Online), Podcast CME, Webinar CME, and Toolkit

    $699.00$635.00
    -10%
    Subscribe
  • Tas gold online only 5

    Gold Level - Newsletters Online-only, Podcast CME, Webinar CME, and Toolkit (Online-Only)

    $649.00$592.00
    -10%
    Subscribe
More Products

Authors

  • Stephanie Brown, PhD
  • Puzantian 150x150
    Talia Puzantian, PharmD, BCPP
  • Alison Knopf
  • Catr 2019 janf qaweaver photo 150x150
    Michael Weaver, MD, FASAM
  • Eliza Wheeler, MA, MS
  • Daniel Carlat, MD
More Authors

ADDICTION TREATMENT - Downloads

Pages

  • The Carlat Addiction Treatment Report (CATR) Editorial Information

Downloads

  • Carlat Clinical Institute Withdrawal Assessment for Alcohol Scale Revised CIWA Argen
  • Inpatient Fact Sheet Managing Opioid Use Disorder in Womengen
  • METHADONE Methadose Fact Sheetgen
More
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • PB5e_3DCover.png

    Psychiatry Practice Boosters, Fifth Edition (2026)

    This fifth edition teaches you the key points of 66 of the most clinically relevant studies in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2772531237.jpg
    General Psychiatry

    Gender Affirming Care in Exile: The Lawsuits

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.